{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:44:21Z","timestamp":1781894661244,"version":"3.54.5"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260483"],"award-info":[{"award-number":["82260483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Biliary tract cancer stands as a prevalent illness, posing significant risks to human health, where immune cells are pivotal in both its development and recovery processes. Due to the diverse functionalities exhibited by different immune cell phenotypes within the organism, and the relatively limited research on their relationship with biliary tract cancer, this study employed Mendelian randomization (MR) to explore their potential association, thereby aiding in a better understanding of the causal link between immune cell phenotypes and biliary tract cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, the causative association of 731 immunophenotype with biliary tract cancer was established using publicly accessible genome-wide association study (GWAS) genetic data through two-sample MR analysis. Sensitivity analyses assess horizontal pleiotropy and heterogeneity of the study findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 731 immunophenotypes examined, a total of 26 immune cell phenotypes were found to exhibit positive results, indicating a significant association with the risk of biliary tract cancer. We confirmed that among these 26 types of immune cells, there are primarily 13 types of B cells; three types of classical dendritic cells (CDCs), including CD80 on myeloid DC, HLA DR on myeloid DC, and Myeloid DC %DC; one type of mature stage T cell,CD4RA on TD CD4+; six types of regulatory T cells; and three types of myeloid cells.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1430551","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T05:06:48Z","timestamp":1720588008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"YaLan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000535733","article-title":"Liver fibrosis is associated with poorer overall survival and higher recurrence rate in patients with cholangiocarcinoma","volume":"41","author":"Steffani","year":"2024","journal-title":"Dig Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41419-020-03286-z","article-title":"Role of Sciellin in gallbladder cancer proliferation and formation of neutrophil extracellular traps","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"216184","DOI":"10.1016\/j.canlet.2023.216184","article-title":"YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer","volume":"563","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.path.2019.11.002","article-title":"Targeted therapy and checkpoint immunotherapy in lung cancer","volume":"13","author":"Ruiz-Cordero","year":"2020","journal-title":"Surg Pathol Clin"},{"key":"B8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/ijms25010543","article-title":"Current and emerging therapeutic targets for the treatment of cholangiocarcinoma: an updated review","volume":"25","author":"Hadfield","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"216675","DOI":"10.1016\/j.canlet.2024.216675","article-title":"Single-cell characterization of infiltrating T cells identifies novel targets for gallbladder cancer immunotherapy","volume":"586","author":"Zhang","year":"2024","journal-title":"Cancer Lett"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S454666","article-title":"The state of systematic therapies in clinic for hepatobiliary cancers","volume":"11","author":"Chen","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-200401000-00023","article-title":"CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma","volume":"28","author":"Fukunaga","year":"2004","journal-title":"Pancreas"},{"key":"B14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhep.2009.03.017","article-title":"Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas","volume":"51","author":"Guedj","year":"2009","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.610","article-title":"Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer","volume":"109","author":"Goeppert","year":"2013","journal-title":"Br J Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature25187","article-title":"High response rate to PD-1 blockade in desmoplastic melanomas","volume":"553","author":"Eroglu","year":"2018","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3892\/ijo","article-title":"Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)","volume":"63","author":"Yang","year":"2023","journal-title":"Int J Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: A review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"B19","doi-asserted-by":"publisher","first-page":"112371","DOI":"10.1016\/j.exger.2024.112371","article-title":"Causal relationship between circulating immune cells and the risk of Alzheimer's disease: A Mendelian randomization study","volume":"187","author":"Xue","year":"2024","journal-title":"Exp Gerontol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2327352","DOI":"10.1080\/15412555.2024.2327352","article-title":"Causal role of immune cells in chronic obstructive pulmonary disease: A two-sample mendelian randomization study","volume":"21","author":"Xiao","year":"2024","journal-title":"COPD"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1308742","article-title":"The causal relationship between gut microbiota and biliary tract cancer: comprehensive bidirectional Mendelian randomization analysis","volume":"14","author":"Wang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18632\/aging.v16i6","article-title":"Relationship between fatty acid intake and aging: a Mendelian randomization study","volume":"16","author":"Chen","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1310083","article-title":"Autoimmune thyroid disease and myasthenia gravis: a study bidirectional Mendelian randomization","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s40120-024-00592-y","article-title":"Impact of immune cells on stroke limited to specific subtypes: evidence from mendelian randomization study","volume":"13","author":"Chen","year":"2024","journal-title":"Neurol Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1327503","article-title":"Causal relationship between gut microbiota and risk of gastroesophageal reflux disease: a genetic correlation and bidirectional Mendelian randomization study","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1333855","article-title":"A mendelian randomization study investigates the causal relationship between immune cell phenotypes and cerebral aneurysm","volume":"15","author":"Shi","year":"2024","journal-title":"Front Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31092","article-title":"Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma","volume":"72","author":"Job","year":"2020","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-0560.2010.01506.x","article-title":"The biologic importance of tumor-infiltrating lymphocytes","author":"Hodi","year":"2010","journal-title":"J Cutan Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40231","article-title":"CD20 deficiency in humans results in impaired T cell-independent antibody responses","volume":"120","author":"Kuijpers","year":"2010","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.10.037","article-title":"Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma","volume":"74","author":"Huang","year":"2021","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.5.1644.1644_1644_1652","article-title":"Apoptosis of Malignant human B cells by ligation of CD20 with monoclonal antibodies","volume":"91","author":"Shan","year":"1998","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-013-2084-3","article-title":"NF-kappaB and STAT3 signaling pathways collaboratively link inflammation to cancer","volume":"4","author":"Fan","year":"2013","journal-title":"Protein Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4317-9","article-title":"B cell-activating factor (BAFF)-targeted B cell therapies in inflammatory bowel diseases","volume":"61","author":"Uzzan","year":"2016","journal-title":"Dig Dis Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"108796","DOI":"10.1016\/j.biopha.2019.108796","article-title":"BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway","volume":"114","author":"Hu","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/79802","article-title":"APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity","volume":"1","author":"Yu","year":"2000","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.0105-2896.2005.00219.x","article-title":"The role of BAFF in immune function and implications for autoimmunity","volume":"204","author":"Kalled","year":"2005","journal-title":"Immunol Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14264","article-title":"Preoperative neutrophil-to-lymphocyte ratio predicts tumor-infiltrating CD8(+) T cells in biliary tract cancer","volume":"40","author":"Tanaka","year":"2020","journal-title":"Anticancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.03.016","article-title":"Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma","volume":"35","author":"Takagi","year":"2004","journal-title":"Hum Pathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jso.10321","article-title":"Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response","volume":"84","author":"Oshikiri","year":"2003","journal-title":"J Surg Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/nu16010073","article-title":"Amurensin G sensitized cholangiocarcinoma to the anti-cancer effect of gemcitabine via the downregulation of cancer stem-like properties","volume":"16","author":"Na","year":"2023","journal-title":"Nutrients"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-011-0110-y","article-title":"NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma","volume":"29","author":"Song","year":"2012","journal-title":"Med Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2005.05.004","article-title":"The role of CD24 in various human epithelial neoplasias","volume":"201","author":"Lim","year":"2005","journal-title":"Pathol Res Pract"},{"key":"B44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12885-018-4147-6","article-title":"High CD8(+) and absence of Foxp3(+) T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival","volume":"18","author":"Fluxa","year":"2018","journal-title":"BMC Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01133-1","article-title":"CD4(+) T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors","volume":"21","author":"Lei","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.5053","article-title":"Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma","volume":"15","author":"Kasper","year":"2009","journal-title":"World J Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0042","article-title":"Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Brown","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1283981","article-title":"Changes in Treg and Breg cells in a healthy pediatric population","volume":"14","author":"Luo","year":"2023","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/vaccines10091471","article-title":"Correlations between circulating and tumor-infiltrating CD4(+) treg subsets with immune checkpoints in colorectal cancer patients with early and advanced stages","volume":"10","author":"Al-Mterin","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13333","article-title":"CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis","volume":"21","author":"Gupta","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2014.12.007","article-title":"The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation","volume":"58","author":"Rissiek","year":"2015","journal-title":"J Autoimmun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.9.6018","article-title":"Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells","volume":"177","author":"Dolan","year":"2006","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12865-016-0186-4","article-title":"Antigen presenting capacity of murine splenic myeloid cells","volume":"18","author":"Hey","year":"2017","journal-title":"BMC Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3109\/1547691X.2013.865094","article-title":"Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy","volume":"11","author":"Rolinski","year":"2014","journal-title":"J Immunotoxicol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"101307","DOI":"10.1016\/j.xcrm.2023.101307","article-title":"Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I\/II first-in-human MATINS trial","volume":"4","author":"Rannikko","year":"2023","journal-title":"Cell Rep Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/vaccines12020165","article-title":"Dendritic cells as a therapeutic strategy in acute myeloid leukemia: vaccines","volume":"12","author":"Palomares","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.73949","article-title":"Tumor microenvironment and its implications for antitumor immunity in cholangiocarcinoma: future perspectives for novel therapies","volume":"18","author":"Cao","year":"2022","journal-title":"Int J Biol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1430551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T05:06:51Z","timestamp":1720588011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1430551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2024.1430551"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1430551","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"article-number":"1430551"}}